On August 1, 2024, Paragon’s visiting research fellow Kev Coleman was referenced in Politco.
From the article:
Artificial intelligence has significant potential to control health care costs, a new report from the conservative Paragon Health Institute found, but several factors could reduce its impact, the group said.
To bolster AI’s potential to reduce costs, the organization argued that clinical assistance shouldn’t be required via regulations in concert with the technology when it meets certain accuracy levels and doesn’t increase health risks.
“One of my concerns around getting regulation that properly balances safety and innovation is … that lobbying groups will advocate that all AI healthcare be supervised by a clinician,” Kev Coleman, a visiting research fellow at Paragon, said at a Wednesday event.
The move comes as lawmakers weigh potential new AI rules and as House GOP leadership has expressed skepticism about any new AI regulation.
